Christophor Jones
Company: Terns Pharmaceuticals
Job title: Director of Biology
Seminars:
Discovery of TERN-501, a Selective THR-Agonist for the Treatment of Non- Alcoholic Steatohepatitis 11:00 am
• Learning about TERN-501: A liver-distributed, highly selective agonist of thyroid hormone receptor beta (THR-b) • Discovering how TERN-501 has been designed to be metabolically stable to reduce pharmacokinetic variability, allowing for a low clinical dose and potential use in a fixeddose combination • Hearing how TERN-501 significantly improves lipid parameters and reduces steatosis in…Read more
day: Day 1 Stream 1 AM